About Us
Privacy Policy
Terms of Service
Use Disclaimer
AfyaChain logo
Cart
Wishlist
Account
Categories
View all categories
Brands
New Arrivals
Trending
Offers
Best Sellers
Vendors
Home / Products

Price Range

Kes11Kes3,000
-

Categories

ACTIVE-IMPLANTABLE DEVICES0CARDIOCIRCULATORY SYSTEM DEVICES0DENTAL, OPHTHALMOLOGIC AND ENT DEVICES0DEVICES FOR ADMINISTRATION, WITHDRAWAL AND COLLECTION0DEVICES FOR GENERAL AND SPECIALIST DRESSINGS0DEVICES FOR PERSONS WITH DISABILITIES NOT INCLUDED IN OTHER CATEGORIES0DEVICES FOR UROGENITAL SYSTEM0DIALYSIS DEVICES0DISINFECTANTS, ANTISEPTICS, STERILISING AGENTS AND DETERGENTS FOR MEDICAL DEVICES0ENDOTHERAPY AND ELECTROSURGICAL DEVICES0GASTROINTESTINAL DEVICES0HAEMATOLOGY AND HAEMOTRANSFUSION DEVICES0IMPLANTABLE PROSTHETIC AND OSTEOSYNTHESIS DEVICES0IN VITRO DIAGNOSTIC MEDICAL DEVICES0MEDICAL EQUIPMENT AND RELATED ACCESSORIES, SOFTWARE AND CONSUMABLES0NERVOUS AND MEDULLARY SYSTEMS DEVICES0PATIENT PROTECTIVE EQUIPMENT AND INCONTINENCE AIDS (EXCLUDING PERSONAL PROTECTIVE EQUIPMENT - PPE)0PRODUCTS WITHOUT AN INTENDED MEDICAL PURPOSE (Annex XVI)0
View all category pages

Brands

Access group antibiotics18Adrenal hormones and synthetic substitutes2Advance3AfyaPharm14American trypanosomiasis2Androgens1Anti-infective medicines1Anti-inflammatory medicines2Anti-platelet medicines1Antiallergics and medicines used in anaphylaxis3Antiamoebic and antigiardiasis medicines3Antianaemia medicines10Antianginal medicines8Antiarrhythmic medicines2Antiasthmatic and medicines for chronic obstructive pulmonary disease17Antidotes and other substances used in poisonings > Non-specific1Antidotes and other substances used in poisonings > Specific13Antiemetic medicines7Antifilarials5Antifungal medicines11Antihypertensive medicines17Antileishmaniasis medicines4Antileprosy medicines3Antimalarial medicines > Medicines for chemoprevention4Antimalarial medicines > Medicines for curative treatment10Antipneumocystosis and antitoxoplasmosis medicines1Antiretrovirals > Integrase inhibitors2Antiretrovirals > Non-nucleoside reverse transcriptase inhibitors2Antiretrovirals > Nucleoside/Nucleotide reverse transcriptase inhibitors4Antiretrovirals > Protease inhibitors4Antischistosomals and other antitrematode medicines4Antiseizure medicines10Antiseptics4Antituberculosis medicines23Antiulcer medicines2Barrier methods2Blood and blood components6Coagulation factors5Cysticidal medicines1Cytotoxic medicines35Dental medicines and preparations5Dermatological medicines1Dermatological medicines > Anti-infective medicines3Dermatological medicines > Anti-inflammatory and antipruritic medicines3Dermatological medicines > Antifungal medicines3Dermatological medicines > Medicines affecting skin differentiation and proliferation15Dermatological medicines > Moisturizers1Dermatological medicines > Scabicides and pediculicides3Diagnostic agents > Ophthalmic medicines3Diagnostic agents > Radiocontrast media4Disease-modifying anti-rheumatic drugs (DMARDs)2Disinfectants5Diuretics6Ear, nose and throat medicines [c]3Fixed-dose combinations for prevention of atherosclerotic cardiovascular disease3Fixed-dose combinations of antiretrovirals8Gastrointestinal medicines1General anaesthetics and oxygen > Inhalational medicines4General anaesthetics and oxygen > Injectable medicines3Hormones and antihormones11Human immunoglobulins4Hypoglycaemic agents9Immunologicals > Diagnostic agents1Immunologicals > Sera, immunoglobulins and monoclonal antibodies4Immunologicals > Vaccines29Immunomodulators9Immunomodulators for non-malignant disease3Implantable contraceptives2Injectable hormonal contraceptives2Insulins10Intestinal anthelminthics3Intrauterine devices1Intravaginal contraceptives2Laxatives2Lipid-lowering agents5Local anaesthetics4Medicines administered to the neonate [c]6Medicines affecting coagulation15Medicines for COVID-191Medicines for Ebola virus disease2Medicines for acute migraine attacks6Medicines for alcohol use disorders2Medicines for anxiety disorders2Medicines for bacterial central nervous system infections2Medicines for bipolar disorders1Medicines for cerebral palsy1Medicines for cystic fibrosis2Medicines for depressive disorders1Medicines for diarrhoea2Medicines for disorders of the pituitary hormone system3Medicines for endocrine disorders1Medicines for haemoglobinopathies2Medicines for hepatitis B > Nucleoside/Nucleotide reverse transcriptase inhibitors1Medicines for hepatitis C > Non-pangenotypic direct-acting antiviral combinations1Medicines for hepatitis C > Other antivirals for hepatitis C1Medicines for hepatitis C > Pangenotypic direct-acting antiviral combinations6Medicines for hypoglycaemia2Medicines for juvenile joint diseases1Medicines for medical abortion2Medicines for multiple sclerosis3Medicines for myasthenia gravis2Medicines for nicotine use disorders4Medicines for obsessive compulsive disorders1Medicines for opioid use disorders2Medicines for other common symptoms in palliative care8Medicines for parkinsonism4Medicines for prevention of HIV-related opportunistic infections1Medicines for psychotic disorders10Medicines for the treatment of 1st stage African trypanosomiasis1Medicines for the treatment of 2nd stage African trypanosomiasis2Medicines for viral central nervous system infections1Medicines used in diarrhoea1Medicines used in heart failure1Medicines used to treat gout1Muscle relaxants (peripherally-acting) and cholinesterase inhibitors3Ophthalmological preparations > Anti-infective agents11Ophthalmological preparations > Anti-inflammatory agents1Ophthalmological preparations > Anti-vascular endothelial growth factor (VEGF) preparations1Ophthalmological preparations > Local anaesthetics1Ophthalmological preparations > Miotics and antiglaucoma medicines5Ophthalmological preparations > Mydriatics3Opioid analgesics4Oral hormonal contraceptives4Oral rehydration1Other antivirals2Other medicines administered to the mother1Ovulation inducers2Peritoneal dialysis solution1PharmaKenya1Plasma substitutes2Progestogens2Reserve group antibiotics9Solutions correcting water, electrolyte and acid-base disturbances > Miscellaneous1Solutions correcting water, electrolyte and acid-base disturbances > Parenteral6Supportive medicines2Targeted therapies12Therapeutic foods1Thrombolytic medicines2Thyroid hormones and antithyroid medicines6Uterotonics4Vitamins and minerals11Watch group antibiotics10

Vendors

Eclat1Eclat Reple0Elea Ventures11Kijana Two1RICHES ORIENTED2Test Company1Test Company 20Test Company 60Test Company 70Testing Company 12Urogi Inc1
Catalogue catalogue banner

Catalogue

Browse procurement-ready healthcare products from trusted vendors across the Afya Chain marketplace.

All Products (Showing 492 out of 662)
Fresh-Frozen Plasma image unavailable
Quote

Fresh-Frozen Plasma

Formulations: - Parenteral > General injections > IV: Indications: - Blood transfusion without reported diagnosis Source: EML workbook import

MOQ: 1
Price on request
Platelets image unavailable
Quote

Platelets

Formulations: - Parenteral > General injections > IV: Indications: - Blood transfusion without reported diagnosis Source: EML workbook import

MOQ: 1
Price on request
Red Blood Cells image unavailable
Quote

Red Blood Cells

Formulations: - Parenteral > General injections > IV: Indications: - Blood transfusion without reported diagnosis Source: EML workbook import

MOQ: 1
Price on request
Whole Blood image unavailable
Quote

Whole Blood

Formulations: - Parenteral > General injections > IV: Indications: - Blood transfusion without reported diagnosis Source: EML workbook import

MOQ: 1
Price on request
Coagulation Factor IX Complex image unavailable
Quote

Coagulation Factor IX Complex

Indications: - Coagulation defects, purpura or other haemorrhagic or related conditions - Haemophilia B Source: EML workbook import

MOQ: 1
Price on request
Coagulation Factor IX, Plasma-Derived image unavailable
Quote

Coagulation Factor IX, Plasma-Derived

Formulations: - Parenteral > General injections > IV: 500 IU in vial powder for injection; 1000 IU in vial powder for injection Indications: - Haemophilia B Source: EML workbook import

MOQ: 1
Price on request
Coagulation Factor IX, Recombinant image unavailable
Quote

Coagulation Factor IX, Recombinant

Formulations: - Parenteral > General injections > IV: 250 IU per mL in vial lyophilized powder for solution for injection; 500 IU in vial lyophilized powder for solution for injection; 1000 IU in vial lyophilized powder for solution for injection; 1500 IU in vial lyophilized powder for solution for injection; 2000 IU in vial lyophilized powder for solution for injection; 3000 IU in vial lyophilized powder for solution for injection; 4000 IU in vial lyophilized powder for solution for injection Indications: - Haemophilia B Source: EML workbook import

MOQ: 1
Price on request
Coagulation Factor VIII, Plasma-Derived image unavailable
Quote

Coagulation Factor VIII, Plasma-Derived

Formulations: - Parenteral > General injections > IV: 250 IU in vial powder for injection; 500 IU in vial powder for injection; 1000 IU in vial powder for injection Indications: - Haemophilia A Source: EML workbook import

MOQ: 1
Price on request
Coagulation Factor VIII, Recombinant image unavailable
Quote

Coagulation Factor VIII, Recombinant

Formulations: - Parenteral > General injections > IV: 250 IU in vial lyophilized powder for solution for injection; 500 IU in vial lyophilized powder for solution for injection; 1000 IU in vial lyophilized powder for solution for injection; 1500 IU in vial lyophilized powder for solution for injection; 2000 IU in vial lyophilized powder for solution for injection; 3000 IU in vial lyophilized powder for solution for injection; 4000 IU in vial lyophilized powder for solution for injection Indications: - Haemophilia A Source: EML workbook import

MOQ: 1
Price on request
Mebendazole image unavailable
Quote

Mebendazole

Formulations: - Oral > Solid > tablet: 100 mg (chewable); 500 mg (chewable) Indications: - Other specified echinococcosis - Ascariasis - Enterobiasis - Trichuriasis - Hookworm diseases Source: EML workbook import

MOQ: 1
Price on request
Arsenic Trioxide image unavailable
Quote

Arsenic Trioxide

Formulations: - Parenteral > General injections > IV: 1 mg per mL concentrate for solution for infusion; 2 mg per mL concentrate for solution for infusion Indications: - Acute myeloid leukaemia with recurrent genetic abnormalities Source: EML workbook import

MOQ: 1
Price on request
Asparaginase image unavailable
Quote

Asparaginase

Formulations: - Powder for injection: 10 000 IU in vial. Parenteral > General injections > unspecified: 10000 IU in vial powder for injection Indications: - Unspecified malignant neoplasms of ill-defined or unspecified sites - Lymphoid leukaemia, not elsewhere classified Source: EML workbook import

MOQ: 1
Price on request
Previous
140414256
Next
Sign Up to Our Newsletter→

Ready to amplify your rewards? Drop your email and we'll be in touch soon.

AfyaChain logo

AfyaChain connects verified healthcare suppliers with institutional buyers through a more reliable and transparent procurement experience.

About Us

About UsPrivacy PolicyTerms of ServiceUse DisclaimerContact Support

Useful Links

Log InRegisterShipping PolicyFAQsReturn Policy

Quick Links

AccountDashboardView CartMy WishlistBest SellersPromotions

Get In Touch

3rd Floor, Building A2, Nairobi

+254 712345678

admin@afyachain.com

Xfino

© 2026 AfyaChain. All rights reserved.

Privacy PolicyTerms of ServiceUse DisclaimerAbout Us